Stifel raised the firm’s price target on Alcon (ALC) to $82 from $80 and keeps a Hold rating on the shares. The firm updated models across its medical technology and supplies coverage following Q4 reporting from the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Goldman Sachs Sees Market Warning Signs – But Likes These 2 Stocks
- Alcon Earnings Call: Growth, Tariffs and Margin Plans
- Spotify upgraded, First Solar downgraded: Wall Street’s top analyst calls
- Wells Fargo upgrades Alcon to Overweight on new product growth
- Alcon price target raised to $90 from $86 at Barclays